• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 21, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Turkish Body Acceptance Scale for Breast Cancer Shows Preliminary Five-Factor Validity

by
November 12, 2026
in Health
Reading Time: 2 mins read
0
Turkish Body Acceptance Scale for Breast Cancer Shows Preliminary Five-Factor Validity

Turkish Body Acceptance Scale for Breast Cancer Shows Preliminary Five-Factor Validity

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A Turkish adaptation of the Body Acceptance Scale for Women with Breast Cancer demonstrated acceptable preliminary psychometric properties while reorganizing the assessment into a five-factor model, according to a methodological evaluation conducted with surgical patients. The study investigated the structural integrity and internal consistency of the measurement tool among Turkish women who had undergone surgical intervention for breast cancer.

The methodological and cross-sectional investigation was carried out between April 2024 and May 2025 within the Department of General Surgery at a hospital. The clinical sample comprised 136 women who had received surgical treatment for breast cancer, providing the primary dataset to evaluate how effectively the assessment translates across cultural and linguistic contexts.

To evaluate the performance of the adapted instrument, the research team assessed linguistic validity, content validity, construct validity, and reliability. Construct validity was examined through both exploratory and confirmatory factor analyses. Reliability metrics included internal consistency assessed via Cronbach’s alpha coefficients, composite reliability calculated across subscales, and average variance extracted to determine convergent validity.

Exploratory factor analysis revealed a modified five-factor structure that accounted for 78.97 percent of the total variance while retaining all 17 items from the original instrument. In this Turkish version, items from the original six-factor scale’s separate “Encounter” and “Adaptation” dimensions merged into a single combined factor designated as “Encounter and Adaptation to the Body.”

Confirmatory factor analysis demonstrated mixed model fit indices, yielding a chi-square to degrees of freedom ratio of 2.69, a comparative fit index of 0.91, a Tucker–Lewis index of 0.89, and a root mean square error of approximation of 0.112. Overall internal consistency remained robust, with Cronbach’s alpha reaching 0.897 across the complete scale and ranging between 0.71 and 0.92 across individual subdimensions. Furthermore, composite reliability exceeded 0.70 across all five subdimensions, and average variance extracted exceeded 0.50 in four of the five subdimensions.

Because the root mean square error of approximation reflected suboptimal fit and both exploratory and confirmatory factor analyses were performed within the same participant cohort, the researchers emphasized that these confirmatory results must be interpreted cautiously. The authors concluded that while the 17-item Turkish version shows preliminary psychometric promise, comprehensive verification in larger and independent cohorts will be essential to establish its generalizability.

Subject of Research: Psychometric validation of the Turkish Body Acceptance Scale for Women with Breast Cancer

Article Title: Validation of the body acceptance scale for women with breast cancer in a Turkish sample

Article References: Yağmur, Y., & Ünal, E. (2026). Validation of the body acceptance scale for women with breast cancer in a Turkish sample. BMC Women's Health. https://doi.org/10.1186/s12905-026-04949-3

Image Credits: AI Generated

DOI: 10.1186/s12905-026-04949-3

Keywords: Body Acceptance Scale for Women with Breast Cancer, BAS-BC, breast cancer surgery, psychometric validation, Turkish sample, exploratory factor analysis, confirmatory factor analysis, construct validity, cross-sectional study, Cronbach's alpha, composite reliability, average variance extracted, Encounter and Adaptation to the Body, model fit indices, hospital surgery department, methodological research

News Source: Nathaniel Bowman. (November 12, 2026). Turkish Body Acceptance Scale for Breast Cancer Shows Preliminary Five-Factor Validity. Scienmag.

Tags: average variance extractedBAS-BCBody Acceptance Scale for Women with Breast Cancerbreast cancer surgerycomposite reliabilityconfirmatory factor analysisconstruct validityCronbach's alphaCross-sectional StudyEncounter and Adaptation to the Bodyexploratory factor analysishospital surgery departmentmethodological researchmodel fit indicesPsychometric ValidationTurkish sample
Share12Tweet7Share2ShareShareShare1

Related Posts

Macao Pandemic Shock Sparked Prolonged Attempted Suicide Surge Without Increasing Deaths

Macao Pandemic Shock Sparked Prolonged Attempted Suicide Surge Without Increasing Deaths

November 21, 2026
Combined Workplace Exposure to Solvents and Noise Linked to Broad Hearing Loss

Combined Workplace Exposure to Solvents and Noise Linked to Broad Hearing Loss

November 21, 2026

Herbal Formula Feibi Recipe No. 2 Attenuates Experimental Lung Fibrosis in Mice

November 21, 2026

Afatinib Controls Rare Compound EGFR-Mutant Lung Cancer for Over 54 Months

November 21, 2026

POPULAR NEWS

  • Combined Workplace Exposure to Solvents and Noise Linked to Broad Hearing Loss

    Combined Workplace Exposure to Solvents and Noise Linked to Broad Hearing Loss

    29 shares
    Share 12 Tweet 7
  • Herbal Formula Feibi Recipe No. 2 Attenuates Experimental Lung Fibrosis in Mice

    29 shares
    Share 12 Tweet 7
  • Afatinib Controls Rare Compound EGFR-Mutant Lung Cancer for Over 54 Months

    29 shares
    Share 12 Tweet 7
  • Perceived Physical Literacy Linked to Healthy Lifestyle Behaviors in University Students

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Syngas Fermentation Broth Promotes Growth of Yarrowia lipolytica T41

Macao Pandemic Shock Sparked Prolonged Attempted Suicide Surge Without Increasing Deaths

Combined Workplace Exposure to Solvents and Noise Linked to Broad Hearing Loss

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.